Aperturetx
1 known investors
Aperture Therapeutics uses machine learning to mine genomic and clinical datasets for naturally occurring protective gene variants, then designs oligonucleotide therapeutics that mimic those variants to treat neurodegenerative diseases such as ALS and FTD and delay brain aging. It targets shared drivers of both familial and sporadic disease, often related to neuroinflammation.
Founders & leadership
MJ
Martin JackoFounder & CEO
Investors · 1
Frequently asked questions
- What does Aperturetx do?
- Aperture Therapeutics uses machine learning to mine genomic and clinical datasets for naturally occurring protective gene variants, then designs oligonucleotide therapeutics that mimic those variants to treat neurodegenerative diseases such as ALS and FTD and delay brain aging. It targets shared drivers of both familial and sporadic disease, often related to neuroinflammation.
- Who founded Aperturetx?
- Aperturetx was founded by Martin Jacko.
- Who are Aperturetx's investors?
- Aperturetx's investors include age1.